NCT01688089View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy
Interventions
DRUG

ODM103

DRUG

Placebo

DRUG

Entacapone

DRUG

Levodopa/carbidopa

Trial Locations (1)

Unknown

Parexel International GmbH, Berlin

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT01688089 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers | Biotech Hunter | Biotech Hunter